Will the US lose measles elimination status in 2026?
$0.00
1
1
Will the US lose measles elimination status in 2026?
$0.00
1
1
AI Analysis
Trader mode: Actionable analysis for identifying opportunities and edge
About This Event
Before Jan 1, 2027 If PAHO's Regional Verification Commission (RVC) determines that endemic measles transmission has been re-established in the United States after Issuance and before Jan 1, 2027, then the market resolves to Yes. Only reporting from any of the Source Agencies qualifies for the purposes of this market. Reports that merely reference prior publications (from before Issuance) do not qualify. Republishing of content originally produced by other sources (e.g., wire services) only qu
What Prediction Markets Are Forecasting
Traders on Kalshi see an 86% chance that the United States will lose its measles elimination status before 2027. That is roughly a 6 in 7 probability. It is a strong consensus, not a sure thing, but close to it.
Elimination status means the country has gone at least 12 months without continuous transmission of the measles virus. The US achieved this in 2000. Losing it would mean the Pan American Health Organization's Regional Verification Commission determines that measles is again circulating endemically here, not just arriving via travelers.
Why the Market Sees It This Way
The main driver is the large measles outbreak that started in Texas and New Mexico in early 2025. As of late March, there were over 400 confirmed cases across multiple states, with most infections in unvaccinated children. The outbreak has already spread beyond the initial region, with cases reported in Oklahoma, Kansas, and Ohio.
Measles is extremely contagious. One infected person can spread it to 12 to 18 others in an unvaccinated population. The US vaccination rate has been declining for years, dropping below the 95% threshold needed for herd immunity in many communities. The CDC reported that kindergarten exemption rates hit a record high in the 2023-2024 school year.
The 12-month clock matters. If transmission continues through the end of 2025, that would meet the definition of re-established endemic transmission. Given how fast measles spreads and how many communities now have low vaccination rates, the market is betting the outbreak will persist that long.
Key Dates and Events to Watch
The RVC typically meets annually to review elimination status. Their next meeting is expected in late 2025 or early 2026. If the outbreak is still active at that point, the declaration could come then.
The real question is whether public health measures can stop the spread before the 12-month mark. Watch for: new vaccination mandates from state governments, changes in school exemption policies, and whether the outbreak jumps into densely populated urban areas with low vaccination rates.
How Reliable Are These Predictions?
Prediction markets have a mixed track record on health policy questions. They did well forecasting COVID-19 vaccine timelines but struggled with complex public health decisions that involve political actors. This particular question depends on both epidemiological reality (whether the virus actually circulates continuously for 12 months) and bureaucratic process (whether the RVC formally declares it). The market is betting the disease will win, but public health officials have stopped large outbreaks before, including a 2019 outbreak that threatened elimination status but was contained.
Current Market Outlook
The market is pricing an 86% chance that the US will lose its measles elimination status before 2027. That is not a close call. This is the market saying the current outbreak in Texas and surrounding states has already done enough damage to trigger a formal determination from the Pan American Health Organization's Regional Verification Commission. The question is not "if" but "when" the RVC will make it official.
Key Factors Driving the Odds
The Texas outbreak has been growing since late January 2025. As of late February, the state reported over 150 confirmed cases, concentrated in Gaines County where vaccination rates are below 80%. That is the real number. Measles needs a 95% vaccination rate for herd immunity. Below 90%, outbreaks become regular. Below 80%, elimination status is gone.
The RVC criteria are straightforward. Endemic transmission means continuous spread for 12 months or more within a defined geographic area. The Texas outbreak started in January 2025. If it continues through January 2026, the clock hits 12 months. The market is pricing 86% because the outbreak shows no signs of stopping. The affected communities have low vaccination rates and strong resistance to public health interventions.
The US lost its elimination status once before in 2019 after a New York outbreak. That took 11 months to resolve. This time the conditions are worse. The 2019 outbreak was contained in Orthodox Jewish communities that had high vaccination rates in the general population. The Texas outbreak is in a region where vaccine skepticism is entrenched and political leadership is hostile to mandates.
What Could Change These Odds
A rapid containment effort could push the odds down. If Texas and New Mexico launch aggressive vaccination campaigns in the affected counties, and if the outbreak stops spreading by mid-2025, the 12-month clock resets. That would require local health departments to overcome community resistance and political opposition. Governor Abbott has not shown interest in mandatory measures.
The other variable is the RVC's timeline. The commission meets periodically. Even if endemic transmission is established, the formal determination could slip past January 1, 2027 if the RVC delays its review. The 14% chance priced into the market reflects that administrative lag, not any real hope of containment.
The Texas outbreak is the largest since 2019 and the pattern matches the pre-elimination era. The market is right to be confident.
AI-generated analysis based on market data. Not financial advice.
Overview
The United States achieved measles elimination in 2000, meaning the disease was no longer continuously present for more than 12 months. This status requires a strong vaccination program and rapid response to imported cases. The Pan American Health Organization (PAHO) Regional Verification Commission (RVC) periodically reviews each country in the Americas to confirm elimination. If the RVC determines the US has lost this status before January 1, 2027, this prediction market resolves to Yes. Measles is highly contagious, with a basic reproduction number (R0) of 12 to 18, meaning one infected person can spread it to many others in a susceptible population. The US has faced several large outbreaks since 2000, including a 2014 outbreak of 383 cases linked to Disneyland and a 2019 outbreak of 1,274 cases centered in Orthodox Jewish communities in New York, which nearly cost the US its elimination status. Recent declines in routine childhood vaccination rates, exacerbated by the COVID-19 pandemic, have raised concerns. In 2024, the US saw 285 measles cases, the highest since 2019, driven partly by undervaccinated communities and international travel. The CDC reported that 89% of children born in 2020 had received their first MMR dose by age 2, down from 92% in 2019. Herd immunity for measles requires at least 95% coverage with two doses. The RVC met in 2023 and reaffirmed US elimination status, but noted increasing risks. A loss of elimination status would have public health, economic, and reputational consequences. It would also signal a broader failure in vaccination infrastructure and could lead to stricter travel advisories or recommendations for additional vaccine doses. This topic interests public health officials, policymakers, vaccine advocates, and anyone tracking the return of preventable diseases.
Historical Context
The US declared measles eliminated in 2000, following a successful vaccination campaign that began in the 1960s. Before the vaccine, measles caused an estimated 3 to 4 million cases and 400 to 500 deaths annually in the US. The elimination status meant that while imported cases could still occur, the disease would not spread for more than 12 months in a defined geographic area. PAHO's RVC has verified elimination for all countries in the Americas since 2016. However, the US faced a major test in 2019 when a large outbreak in New York City and Rockland County lasted from September 2018 to August 2019, totaling 1,274 cases. This outbreak was linked to travel to Israel and spread within undervaccinated Orthodox Jewish communities. The US narrowly retained elimination status because the outbreak ended within 12 months. In 2014, a smaller outbreak of 383 cases linked to Disneyland in California also raised concerns. These events highlighted vulnerabilities in vaccination coverage, particularly in communities with philosophical or religious exemptions. The COVID-19 pandemic further disrupted routine childhood vaccinations, with CDC data showing that kindergarten MMR coverage fell from 95.2% in the 2019-2020 school year to 93.1% in the 2022-2023 school year. The pandemic also increased vaccine hesitancy and skepticism about public health authorities. In 2024, cases rose again, with 285 reported by late December, driven by outbreaks in undervaccinated communities in Illinois, Ohio, and other states. The RVC's 2023 report cited the US as having a moderate risk of losing elimination, noting that multiple jurisdictions had vaccination rates below 90%.
Why It Matters
Loss of measles elimination status would have immediate public health consequences. It would mean that the US can no longer contain the virus through vaccination and outbreak response alone, indicating sustained transmission. This would likely lead to more cases, hospitalizations, and deaths, especially among infants too young to vaccinate and immunocompromised individuals. Economically, each measles case costs an estimated $50,000 to $100,000 in public health response, including contact tracing, quarantine, and medical care. A large outbreak could cost millions. Politically, losing elimination status would be a major embarrassment for US public health agencies and could undermine international trust. It might also trigger travel advisories from other countries or require US travelers to show proof of vaccination. Socially, it would amplify debates about vaccine mandates and school immunization requirements. Parents may face more pressure to vaccinate, while anti-vaccine groups might use the news to argue that vaccines are ineffective. The long-term consequence is a potential reversal of decades of progress against a disease that was once a leading cause of childhood death. Other countries that have lost elimination status, like Venezuela in 2018, saw large resurgences. The US has stronger infrastructure, but the trend is worrying.
Current Status
As of early 2025, the US has not lost measles elimination status. The PAHO RVC last reviewed the US in 2023 and reaffirmed elimination, but with a moderate risk rating. The CDC continues to monitor outbreaks. In 2024, major outbreaks occurred in Chicago (57 cases) and Ohio (100+ cases), primarily in undervaccinated communities. The CDC has issued multiple health alerts and is working with state health departments to improve vaccination coverage. The 2025 outlook depends on whether vaccination rates recover and whether large outbreaks can be contained within 12 months. If a sustained outbreak occurs, the RVC could declare re-establishment of endemic transmission. The next RVC meeting is expected in 2025 or 2026, but the committee can meet earlier if needed.
Frequently Asked Questions
What does it mean for the US to lose measles elimination status?
It means that the Pan American Health Organization (PAHO) determines that measles has been continuously present in the US for more than 12 months, indicating that the disease is no longer just imported but is spreading locally. This would require a formal declaration by PAHO's Regional Verification Commission.
How many measles cases would cause the US to lose elimination status?
There is no specific case count. The key factor is sustained transmission in a defined geographic area for over 12 months. Even a few hundred cases could trigger loss if they form a continuous chain of local spread lasting more than a year.
What is the difference between elimination and eradication of measles?
Elimination means no continuous transmission in a specific region (like the US) for 12 months. Eradication means the global elimination of the disease, with no new cases anywhere. Measles has been eliminated in the Americas but not globally.
How can the US regain measles elimination status if it loses it?
The US would need to interrupt all endemic transmission for 12 consecutive months, demonstrate high vaccination coverage (over 95%) and strong surveillance, and then apply to PAHO for re-verification. This process could take years.
Educational content is AI-generated and sourced from Wikipedia. It should not be considered financial advice.
